| Term 
 
        | At the prenantal visit obtain basic historical information about the woman and family concerning----------? (3) |  | Definition 
 
        | diseases, surgeries, and deaths |  | 
        |  | 
        
        | Term 
 
        | Ask if the pt. has been treated for--------?(9) |  | Definition 
 
        | kidney or bladder problems;high BP;heart disease;rheumatic fever; hypo or hyper thyroidism;DM; allergies to any foods, drugs, or environmental substances; or STDs |  | 
        |  | 
        
        | Term 
 
        | Ask if the pt. has been exposed to any ___ since b4 becoming pregnant. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Also remember to ask if the pt has ever received_____or_____; and if the pt _____. |  | Definition 
 
        | Blood or blood products: smokes |  | 
        |  | 
        
        | Term 
 
        | Request the approximate date of the last _____ and results. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gather data about menstrual pattern such as_____(5) and if any ____ are used. |  | Definition 
 
        | age of onset,duration and frequency, date of last full cycle,any bleeding since; contraceptives |  | 
        |  | 
        
        | Term 
 
        | Take an obstetric history including____(6) |  | Definition 
 
        | previous live births,stillbirths,miscarriages orinduced abortions,c-sections, or if Rho(d) immune globulin (RhoGam)was needed for incompatibility. |  | 
        |  | 
        
        | Term 
 
        | If any previous deliveries were premature obtain info about___(4) |  | Definition 
 
        | age of gestation, survival of child, suspected cause, or infection. |  | 
        |  | 
        
        | Term 
 
        | Obtain a nutritional history including___(8) |  | Definition 
 
        | pts usual wt;how much wt gained or lost in th epast 3 months;favorite foods;foods she avoids;how often does she eat;what has she eaten in the last 3 days;does she take a vitamin, mineral or herb products;cultural food practices to be observed during preganacy. |  | 
        |  | 
        
        | Term 
 
        | Psychosocial culture history including ___ (6) |  | Definition 
 
        | how does she feel about the pregnancy; cultural practices to follow during pregnancy; what makes up her support group; employment status;level of education, economic status. |  | 
        |  | 
        
        | Term 
 
        | Take a med. history including___(5) |  | Definition 
 
        | any prescribed, OTC, herbals;alcohol and street drugs, |  | 
        |  | 
        
        | Term 
 
        | If she is not currently taking any meds. ask whether any have been taken over the past___ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Include _(7)__ in the physical exam |  | Definition 
 
        | ht and wt; BP (hx of hypertension?); heart rate (take for one full min);respirations;temp;urine specimen;cbc |  | 
        |  | 
        
        | Term 
 
        | Assessment done at routine visits during pregnancy includes: (6) |  | Definition 
 
        | wt; bp;p; resp;abd measurement including fundal height and fetal heart sounds;any problems or concerns |  | 
        |  | 
        
        | Term 
 
        | The pregnant woman who does not experience complications is usually examined ___for the first 6 months;every___in the 7th and 8th month; and ____in the 9th month. |  | Definition 
 
        | monthly;every 2 weeks; weekly |  | 
        |  | 
        
        | Term 
 
        | S&S of potential obstetric complications are: (10) |  | Definition 
 
        | infection;hyperemesis gravidarum;miscarriage;abortion;preterm labor;premature membrane rupture;GDM;hypertension;intrauterine fetal death; and HELLP syndrome (hemolysis elevated liver enzymes and low platelet count) |  | 
        |  | 
        
        | Term 
 
        | Assess the status of the fetus by___(5) |  | Definition 
 
        | fetal movement counts, contraction stress testing, biophysical profile, ultrasound, or amniocentesis. |  | 
        |  | 
        
        | Term 
 
        | When giving magnesium sulfate for pregnancy-induced hypertension (PIH) be sure to assess____(6) |  | Definition 
 
        | deep tendon reflexes; respiratory status;sedation level;I&O; seizure precauctions and cardiac status |  | 
        |  | 
        
        | Term 
 
        | ___ is the antidote for mag sulfate. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | After delivery the VS should be checked ____ |  | Definition 
 
        | every 15 mins for the first hour or until stable then every 30 mins for the nest 2  hrs |  | 
        |  | 
        
        | Term 
 
        | After delivery inspect the ___ and note any abnormal swelling or bruising |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Assess the fundal ___ &___ every 15 mins for 1 hr and then every 30 mins for the next 4 hrs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Describe the amount of ___ and the color and presence of clots every ___ mins for 1 hr; every___ for the next 4 hrs; and ___ for the next 12 hrs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Assess breasts for ___&___ approx.3-4 hrs postpardum |  | Definition 
 
        | colestrum/breastmilk; engorgement/discomfort |  | 
        |  | 
        
        | Term 
 
        | Assessment of the neonate includes___(4) |  | Definition 
 
        | patent airway;umbilical cord is observed till pulsation ceases then clamped;apgar at 1 and 5 mins;rapid gestational age assessment |  | 
        |  | 
        
        | Term 
 
        | There are four primary clinical indications for the use of uterine stimulants |  | Definition 
 
        | induction or augmentation of labor; control of postpardum atony and hemorrhage;control of post surgical hemorrhage (c-section);induction of therapeutic abortion. |  | 
        |  | 
        
        | Term 
 
        | ____ using a uterine stimulant like___ may be used in cases where cont. of the pregnancy is considered to be greater risk to the mother or fetus than the risk assoc. with induced labor. |  | Definition 
 
        | Induction of labor;oxytocin |  | 
        |  | 
        
        | Term 
 
        | A Hx of___(5)__ may indicate the need to induce labor. |  | Definition 
 
        | precipitous labor and delivary; postterm pregnancy;prolonged preg. with placental insufficency;prolonged rupture of membranes;pregnancy induced hypertension |  | 
        |  | 
        
        | Term 
 
        | Vaginal inserts,gels and PO forms of _____are being tested as adj. therapy to help ripen the cervix |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In general ____ should not be used to hasten labor.The type and force of contraction induced may be harmful to the mother or fetus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In occasional cases of ___ there is a prolonged latent phase of cervical dilation or arrest of descent through the birth canal. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ___&____ may be useful in cases of dysfunctional labor. |  | Definition 
 
        | low dosages of oxytocin and  continuous fetal monitoring |  | 
        |  | 
        
        | Term 
 
        | After delivery the uterus sometimes remains___&___ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ____or____ may be used in cases of post pardum atony or hemmorrhage |  | Definition 
 
        | continued iv low-dose oxytocin or IM inj. of ergonovine or methylergonovine |  | 
        |  | 
        
        | Term 
 
        | Occasionally oral doeses of ___or___ are admin. for a few days after delivary to assist in uterine involution. |  | Definition 
 
        | ergonovine oor methylergonovine |  | 
        |  | 
        
        | Term 
 
        | Various dosage forms of ___ or ____ may be effective in eveacuating uterine contents. |  | Definition 
 
        | prostaglandins or hypertonic(20%)sodium chloride |  | 
        |  | 
        
        | Term 
 
        | Uterine smooth muscle is not very responsive to ____stimulation until late in the thirs trimester so it isn't indicated in therapeutic abortion. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Regardless of the stage of pregnancy stimulans such as ____or__ may be prescribed after the uterus is emptied to control bleeding and maintain uterine muscle tone. |  | Definition 
 
        | ergonovine or methylergonovine |  | 
        |  | 
        
        | Term 
 
        | ____ is a natural chemical in the body that causes uterine and GI smooth muscle stimulation. |  | Definition 
 
        | Dinoprostone (prostaglandin E2) |  | 
        |  | 
        
        | Term 
 
        | Dinoprostone also plays an active role in ___and ___unrelated to uterine muscle stimulation. |  | Definition 
 
        | cervical softening and dilation(cervical ripening) |  | 
        |  | 
        
        | Term 
 
        | In higher doses dinoprostone increases ____&____ of contractions |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dinoprostone is used to start and continue___. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In large doses dinoprostone is used to expel uterine contents in cases of___(4) |  | Definition 
 
        | intrauterine fetal death;benign hydatidiform mole;spontaneous miscarriage;and 2nd trimester abortion. |  | 
        |  | 
        
        | Term 
 
        | Occasionally dinoprostone and ___are used together to shorten the duration of time required to expel uterine contents. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The primary therapeutic outcomes assoc. with dinoprostone therapy are:(2) |  | Definition 
 
        | cervical softening and dilation b4 labor and evacuation of uterine contents |  | 
        |  | 
        
        | Term 
 
        | What is the premed assessment for dinoprostone(4) |  | Definition 
 
        | baseline VS, every half hour after initiation of therapy;assess state of hydration;assess uterine activity including discharge;chk for antiemetic and anyidiarrheal meds ordered. |  | 
        |  | 
        
        | Term 
 
        | Side effects to expect with dinoprostone therapy |  | Definition 
 
        | nausea, vomiting, diarrhea,fever |  | 
        |  | 
        
        | Term 
 
        | Temp elevations to ____ occur within __to__ and continue for up to 6 hrs. with dinoprostone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ___does not inhibit dinoprostone-induced fever |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | side effects to report with with dinoprostone therapy are |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______is a synthetic prostaglandin E used to prevent nonsteroidal antiinflammatory drug induced ulcer disease. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The ____also induce uterine contractions in the pregnant uterus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | misoprostol is not approved by the ___ as a cervical ripening agent, induction of labor,or Tx of serious postpardum hemorrhage with uterine atony. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Misoprostol is used in combo with____ as an abortifacient. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Misoprostol should not be used to induce labor in women with a Hx of ___ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | therapeutic outcomes of misorostol therapy are: |  | Definition 
 
        | cervical softening and dilation;induction of active labor;reduction of postpardum hemorrhage in th presence of uterine atony;evacuation of uterine contents |  | 
        |  | 
        
        | Term 
 
        | Premed assessment of Misoprostol (4) |  | Definition 
 
        | baseline VS monitored every half hr;state of hydration;uterine activity& discharge;antemetic & antidiarrheal meds |  | 
        |  | 
        
        | Term 
 
        | Rare  adverse effects of misoprostol may include__ |  | Definition 
 
        | uterine hyperstimulation with subsequent fetal hypoxia,uterine rupture,amniotic fluid embolism |  | 
        |  | 
        
        | Term 
 
        | ____&__produce more sustained contractions than oxytocin and are used in small doses in postpardum pts.to control bleeding and maintain uterine firmness. |  | Definition 
 
        | ergonovine & methylergonovine |  | 
        |  | 
        
        | Term 
 
        | the primary therapeutic outcome assoc with ergonovine and methylergonovine therapy is |  | Definition 
 
        | reduced postpardum blood loss |  | 
        |  | 
        
        | Term 
 
        | premed assessment for ergonovine and methylergonovine is |  | Definition 
 
        | base VS and amount and characteristics of discharge,fundal height and contractility |  | 
        |  | 
        
        | Term 
 
        | side effects to expect with ergonovine and methylergonovine are |  | Definition 
 
        | nausea,vomiting,abd cramping, |  | 
        |  | 
        
        | Term 
 
        | SE to report with methylgonovine and ergonovine are |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | hypertension and headaches may develop in pts.who have received ___followed by a dosage of ergonovine or methylergonovine |  | Definition 
 
        | caudal or spinal anesthesia |  | 
        |  | 
        
        | Term 
 
        | oxytocin is a hormone produced in the __ and stored in the ___ |  | Definition 
 
        | hypothalamus;pituitary gland |  | 
        |  | 
        
        | Term 
 
        | when oxytocin is released it stimulates the smooth muscles of____ |  | Definition 
 
        | uterus;mammory glands and blood vessels |  | 
        |  | 
        
        | Term 
 
        | oxytocin is the drug of choice for ___and ___ |  | Definition 
 
        | inducing labor and for augmentation  of uterine contractions |  | 
        |  | 
        
        | Term 
 
        | oxytocin is routinely admin. immediately postpardum to control___&__ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Therapeutic outcomes assoc with oxytocin therapy are |  | Definition 
 
        | initiation of labor;support of uterine contractions and control of potpardum bleeding |  | 
        |  | 
        
        | Term 
 
        | SE to expect with oxytocin therapy are |  | Definition 
 
        | uterine contractions nausea and vomiting |  | 
        |  | 
        
        | Term 
 
        | Contractions longer than ___ require the flow rate of the oxytocin to be slowed or discontinued |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SE to report with oxytocin therapy are |  | Definition 
 
        | fetal distress,hypertension,hypotension,water intoxicaton, dehydration,postpardum hemorrhage. |  | 
        |  | 
        
        | Term 
 
        | ___aka ___ are used primarily to delay or prevent preterm L&D in selected pts. |  | Definition 
 
        | uterine relaxants aka tocolytic agents |  | 
        |  | 
        
        | Term 
 
        | Tocolytic agents act by inhibiting ___ |  | Definition 
 
        | uterine muscle contractions |  | 
        |  | 
        
        | Term 
 
        | Tocolytic agents are most commonly  used to inhibit labor for __ to __ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mag sulfate is used primarily to inhibit___or control____ |  | Definition 
 
        | premature labor;seizures assoc with preeclampsia |  | 
        |  | 
        
        | Term 
 
        | when mag sulfate is used as an anticonvulsant or to inhibit labor blood levels shoild be maintained at __to__ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | at levels aprrox 5-8 to  mEq/L pts begin to show signs of __ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Therapeutic outcomes expected with mag sulfate are; |  | Definition 
 
        | arrest of preterm labor;elimination of seizure activity |  | 
        |  | 
        
        | Term 
 
        | premed assessment for mag sulfate is |  | Definition 
 
        | base Vs;mental status;deep tendon reflexes;I&O; have calcium gluconate or calcium gluconate with Iv admin equip available; base serum mag level; fetal heart rate ,uterine activity monitoring |  | 
        |  | 
        
        | Term 
 
        | Se to report with mag sulfate |  | Definition 
 
        | deep tendon reflexes,I&O,VS,confusion,overdose |  | 
        |  | 
        
        | Term 
 
        | Infants born to mothers who receive magnesium sulfate must be monitored for |  | Definition 
 
        | hypotension,hyporeflexia and resp. depression |  | 
        |  | 
        
        | Term 
 
        | The primary therapeutic outcome assoc. with terbutaline therapy is___ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Se to report with terbutaline sulfate |  | Definition 
 
        | tachycardia,palpitations hypertension,hypotension,tremors,nervousness,anxiety,restlessness,headache, nausea, vomiting dizziness, hyperglycemia,electrolyte imbalance. |  | 
        |  |